Loading…
Benefit of Anticoagulation Therapy in Hyperthyroidism‐Related Atrial Fibrillation
ABSTRACT Background Existing data on the risk of ischemic stroke in hyperthyroidism‐related atrial fibrillation (AF) and the impact of long‐term anticoagulation in these patients, particularly those with self‐limiting AF, remain inconclusive. Hypothesis Risk of stroke in hyperthyroidism‐related AF i...
Saved in:
Published in: | Clinical cardiology (Mahwah, N.J.) N.J.), 2015-08, Vol.38 (8), p.476-482 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | ABSTRACT
Background
Existing data on the risk of ischemic stroke in hyperthyroidism‐related atrial fibrillation (AF) and the impact of long‐term anticoagulation in these patients, particularly those with self‐limiting AF, remain inconclusive.
Hypothesis
Risk of stroke in hyperthyroidism‐related AF is the same as nonhyperthyroid counterparts.
Methods
This was a single‐center observational study of 9727 Chinese patients with nonvalvular AF from July 1997 to December 2011. Patients with AF diagnosed concomitantly with hyperthyroidism were identified. Primary and secondary endpoints were defined as hospitalization with ischemic stroke and intracranial hemorrhage in the first 2 years. Patient characteristics, duration of AF, and choice of antithrombotic therapy were recorded. Self‐limiting AF was defined as |
---|---|
ISSN: | 0160-9289 1932-8737 |
DOI: | 10.1002/clc.22427 |